在稳定型COPD中，长效毒蕈碱拮抗剂加长效β受体激动剂比长效β受体激动剂加吸入皮质类固醇导致更少的加重、肺炎和更大的FEV 1改善。

{"title":"在稳定型COPD中，长效毒蕈碱拮抗剂加长效β受体激动剂比长效β受体激动剂加吸入皮质类固醇导致更少的加重、肺炎和更大的FEV 1改善。","authors":"Mario Cazzola, Paola Rogliani","doi":"10.1136/ebmed-2017-110726","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":"22 5","pages":"183-184"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV _₁ than long-acting beta-agonists plus inhaled corticosteroids.\",\"authors\":\"Mario Cazzola, Paola Rogliani\",\"doi\":\"10.1136/ebmed-2017-110726\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12182,\"journal\":{\"name\":\"Evidence-Based Medicine\",\"volume\":\"22 5\",\"pages\":\"183-184\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-Based Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ebmed-2017-110726\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/8/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-Based Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ebmed-2017-110726","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/8/11 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}